FOREGEN IS A REGISTERED AND TAX EXEMPT 501(C)(3) NON-PROFIT ORGANIZATION FOUNDED TO RESEARCH AND IMPLEMENT REGENERATIVE MEDICAL THERAPIES FOR CIRCUMCISED MALES.
Foregen’s mission is to heal the physical and psychological damage inherent to circumcision through tissue engineering techniques, which offer outstanding potential to regrow human tissue, especially dermal tissue, lost in trauma.
Because regenerative medicine techniques have not yet been applied to circumcised men, Foregen was formed to initiate novel research and clinical trials. Dedicated Foregen scientists are transferring well-known, tested, and state-of-the-art techniques to the mission to re-establish normal penile sensitivity with a fully functioning foreskin.
A unique organization, Foregen’s mission contributes to the growing applications of regenerative medicine and has implications for over one billion people - circumcised men and their partners! Foregen has received countless testimonials and expressions of hope for the potential of regenerative medicine in resolving the damage of circumcision.
Foregen is not an activist organization and has no legislative or political agenda. Rather, Foregen is a pioneering research organization dedicated to creating options and hope for circumcised men.
Foregen is a 501(c)(3) non-profit organization founded to research and implement regenerative medical therapies for circumcised men. Thanks to an initial cohort of contributing donors, Foregen was created in 2010 with the goal of finding existing institutions to conduct research. In time, we found that the only way to accomplish our goals would be to establish our own scientific team and conduct the necessary research ourselves. After searching carefully for the right people, our scientific team was created and initial research started in 2014. Foregen now operates in both the United States and the European Union. Its head office is in Rome, Italy, where it is a registered charity (Reg. No. 6482, Serie 1T, 2010) and maintains domicile in the United States under section 501(c)(3) of the Internal Revenue Code. It is headed by a board of directors with volunteers and donors from over 80 countries across 6 continents.
Foregen’s Board of Directors leads the mission with the help of dedicated officers, staff, scientists, and advisers. Founder, Vincenzo Aiello, heads the Board of Directors and is assisted by a vice president and advisory board.